Taken all this into account, our interpretation is that p65 modulates circadian genes in the colon in the pro-inflammatory pro-tumorigenic condition, and that ERβ can change this and thereby oppose the inflammatory condition that drives development of colon cancer. Here, ESR2 is linked to malignant colon neoplasm.